SCHEMBL21600780

SCHEMBL21600780

CN(C)CCOc1ccc(Nc2ncc(C#N)c(Nc3ccccc3)n2)c([N+](=O)[O-])c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.45
▸ AURKA O14965 3/20 0.45
▸ GSK3A P49840 2/20 0.45
▸ SYK P43405 1/20 0.41
▸ PLK1 P53350 2/20 0.41
▸ EGFR P00533 2/20 0.40
▸ CHRNB2 P17787 1/20 0.39
▸ CHRNA4 P43681 1/20 0.39
▸ KDR P35968 3/20 0.38
▸ CDK1 P06493 2/20 0.38
▸ PTK2 Q05397 1/20 0.37
▸ LRRK2 Q5S007 2/20 0.37
▸ CDK4 P11802 2/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CDK6 Q00534 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600778 0.89 GSK3B (0.47) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL28537290 0.82 EGFR (0.46) AURKASYKPLK1EGFRLRRK2
SCHEMBL21596345 0.82 SYK (0.42) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL21600790 0.81 MAPK3 (0.52) EGFR
SCHEMBL21596390 0.81 AURKA (0.58) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL30379300 0.81 AURKA (0.58) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL21596344 0.75 GSK3B (0.54) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL30380004 0.75 GSK3B (0.54) GSK3BAURKAGSK3ASYKPLK1
SCHEMBL21596346 0.74 CDK1 (0.55) GSK3BAURKAEGFRKDRCDK1
SCHEMBL30380205 0.74 CDK1 (0.55) GSK3BAURKAEGFRKDRCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback